{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:52:59Z","timestamp":1788274379576,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Elevation of systemic inflammatory markers were found to correlate with increased disease extent, reduced lung function and higher risk of future severe exacerbations in patients with bronchiectasis. Although a significant correlation of circulating hs-CRP levels with HRCT scores and resting oxygen saturation in patients with stable-state non-cystic fibrosis (CF) bronchiectasis was suggested, there is little data on the relationship between hs-CRP and the prognosis of bronchiectasis and a lack of data on the role of hs-CRP in predicting bronchiectasis exacerbation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective study was conducted on Chinese patients with non- CF bronchiectasis from 1st October to 31st December 2021. Baseline serum hs-CRP were obtained at stable-state. The follow-up period lasted for one year. Co-primary endpoints were the development of any bronchiectasis exacerbation and hospitalized bronchiectasis exacerbation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Totally 123 patients were included. Higher hs-CRP was associated with increased risk to develop any bronchiectasis exacerbation, adjusted odds ratio (aOR) of 2.254 (95% CI\u2009=\u20091.040\u20134.885, <jats:italic>p<\/jats:italic>\u2009=\u20090.039), and borderline significantly increased hospitalized bronchiectasis exacerbation with aOR of 1.985 (95% CI\u2009=\u20090.922\u20134.277, <jats:italic>p<\/jats:italic>\u2009=\u20090.080).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Baseline serum hs-CRP level at stable-state can predict risk of bronchiectasis exacerbation, which is reflecting chronic low-grade inflammation in bronchiectasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-024-02888-z","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T11:02:40Z","timestamp":1707822160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk"],"prefix":"10.1186","volume":"24","author":[{"given":"Wang Chun","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Cheong","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui Kai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Chung-man","family":"HO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"key":"2888_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev-pathol-012615-044344","volume":"11","author":"RJ Boyton","year":"2016","unstructured":"Boyton RJ, Altmann DM. Bronchiectasis: current concepts in Pathogenesis, Immunology, and Microbiology. Annu Rev Pathol. 2016;11:523\u201354.","journal-title":"Annu Rev Pathol"},{"key":"2888_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1183\/09031936.00069007","volume":"31","author":"S Fuschillo","year":"2008","unstructured":"Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J. 2008;31:396\u2013406.","journal-title":"Eur Respir J"},{"key":"2888_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1378\/chest.117.2.420","volume":"117","author":"KW Tsang","year":"2000","unstructured":"Tsang KW, Chan K, Ho P, et al. Sputum elastase in steady-state bronchiectasis. Chest. 2000;117:420\u20136.","journal-title":"Chest"},{"key":"2888_CR4","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1378\/chest.114.6.1594","volume":"114","author":"PL Ho","year":"1998","unstructured":"Ho PL, Chan KN, Ip MS, et al. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest. 1998;114:1594\u20138.","journal-title":"Chest"},{"key":"2888_CR5","doi-asserted-by":"crossref","unstructured":"Dente FL, Bilotta M, Bartoli ML et al.,. Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis. Mediators Inflamm 2015; 2015: 642503","DOI":"10.1155\/2015\/642503"},{"key":"2888_CR6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1183\/09031936.98.12040820","volume":"12","author":"CB Wilson","year":"1998","unstructured":"Wilson CB, Jones PW, O\u2019Leary CJ, et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J. 1998;12:820\u20134.","journal-title":"Eur Respir J"},{"key":"2888_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.arbr.2019.12.022","volume":"57","author":"T Posadas","year":"2021","unstructured":"Posadas T, Oscullo G, Zaldivar E, et al. C-Reactive protein concentration in steady-state bronchiectasis: prognostic value of future severe exacerbations. Data from the Spanish Registry of Bronchiectasis (RIBRON). Arch Bronconeumol (Engl Ed). 2021;57:21\u20137.","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"2888_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrrheum.2009.29","volume":"5","author":"MJ Kaplan","year":"2009","unstructured":"Kaplan MJ. Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol. 2009;5:208\u201317.","journal-title":"Nat Rev Rheumatol"},{"key":"2888_CR9","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/j.jacc.2006.09.030","volume":"48","author":"BM Everett","year":"2006","unstructured":"Everett BM, Kurth T, Buring JE, et al. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol. 2006;48:2235\u201342.","journal-title":"J Am Coll Cardiol"},{"key":"2888_CR10","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","volume":"285","author":"PM Ridker","year":"2001","unstructured":"Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481\u20135.","journal-title":"JAMA"},{"key":"2888_CR11","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/01.CIR.0000097109.90783.FC","volume":"108","author":"M Cesari","year":"2003","unstructured":"Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108:2317\u201322.","journal-title":"Circulation"},{"key":"2888_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/01.CIR.0000053731.05365.5A","volume":"107","author":"ET Yeh","year":"2003","unstructured":"Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370\u20131.","journal-title":"Circulation"},{"key":"2888_CR13","doi-asserted-by":"crossref","unstructured":"Hsieh MH, Fang YF, Chen GY et al.,. The role of the high-sensitivity C-reactive protein in patients with stable non-cystic fibrosis bronchiectasis. Pulm Med 2013; 2013: 795140","DOI":"10.1155\/2013\/795140"},{"key":"2888_CR14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189:576\u201385.","journal-title":"Am J Respir Crit Care Med"},{"key":"2888_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","volume":"186","author":"JD Chalmers","year":"2012","unstructured":"Chalmers JD, Smith MP, McHugh BJ, et al. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2012;186:657\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"2888_CR16","doi-asserted-by":"crossref","unstructured":"Kapur N, Masters IB, Chang AB. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability? Chest 2010; 138: 158\u2013164.","DOI":"10.1378\/chest.09-2932"},{"key":"2888_CR17","doi-asserted-by":"crossref","unstructured":"Polverino E, Goeminne PC, McDonnell MJ et al.,. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50","DOI":"10.1183\/13993003.00629-2017"},{"key":"2888_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1183\/09031936.02.00284602","volume":"20","author":"RE Sheehan","year":"2002","unstructured":"Sheehan RE, Wells AU, Copley SJ, et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J. 2002;20:581\u20137.","journal-title":"Eur Respir J"},{"key":"2888_CR19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1378\/chest.10-0099","volume":"138","author":"AE Seitz","year":"2010","unstructured":"Seitz AE, Olivier KN, Steiner CA, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993\u20132006. Chest. 2010;138:944\u20139.","journal-title":"Chest"},{"key":"2888_CR20","doi-asserted-by":"publisher","first-page":"e71109","DOI":"10.1371\/journal.pone.0071109","volume":"8","author":"FC Ringshausen","year":"2013","unstructured":"Ringshausen FC, de Roux A, Pletz MW, et al. Bronchiectasis-associated hospitalizations in Germany, 2005\u20132011: a population-based study of disease burden and trends. PLoS ONE. 2013;8:e71109.","journal-title":"PLoS ONE"},{"key":"2888_CR21","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","volume":"4","author":"MJ McDonnell","year":"2016","unstructured":"McDonnell MJ, Aliberti S, Goeminne PC, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4:969\u201379.","journal-title":"Lancet Respir Med"},{"key":"2888_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jamda.2016.01.007","volume":"17","author":"RJ Beijers","year":"2016","unstructured":"Beijers RJ, van den Borst B, Newman AB, et al. A multidimensional risk score to Predict all-cause hospitalization in Community-Dwelling older individuals with obstructive lung disease. J Am Med Dir Assoc. 2016;17:508\u201313.","journal-title":"J Am Med Dir Assoc"},{"key":"2888_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/ppul.23744","volume":"52","author":"J Xu","year":"2017","unstructured":"Xu J, Yin Y, Zhang L, et al. Four case reports of Chinese cystic fibrosis patients and literature review. Pediatr Pulmonol. 2017;52:1020\u20138.","journal-title":"Pediatr Pulmonol"},{"key":"2888_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/COPD.S121943","volume":"12","author":"MA Martinez-Garcia","year":"2017","unstructured":"Martinez-Garcia MA, Athanazio RA, Giron R, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J Chron Obstruct Pulmon Dis. 2017;12:275\u201384.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2888_CR25","doi-asserted-by":"crossref","unstructured":"Hill AT, Haworth CS, Aliberti S et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J 2017; 49.","DOI":"10.1183\/13993003.00051-2017"},{"key":"2888_CR26","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1183\/09031936.00026313","volume":"43","author":"MA Martinez-Garcia","year":"2014","unstructured":"Martinez-Garcia MA, de Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43:1357\u201367.","journal-title":"Eur Respir J"},{"key":"2888_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cyto.2017.08.005","volume":"99","author":"S Tsikrika","year":"2017","unstructured":"Tsikrika S, Dimakou K, Papaioannou AI, et al. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis. Cytokine. 2017;99:281\u20136.","journal-title":"Cytokine"},{"key":"2888_CR28","doi-asserted-by":"crossref","unstructured":"Shoemark A, Cant E, Carreto L et al. A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation. Eur Respir J 2019; 53.","DOI":"10.1183\/13993003.congress-2019.OA4947"},{"key":"2888_CR29","first-page":"177","volume":"31","author":"F Niyi-Odumosu","year":"2016","unstructured":"Niyi-Odumosu F, Bello O, Biliaminu S, et al. Resting serum concentration of high-sensitivity C-reactive protein (hs-CRP) in sportsmen and untrained male adults. Nigerian J Physiological Sci. 2016;31:177\u201381.","journal-title":"Nigerian J Physiological Sci"},{"key":"2888_CR30","doi-asserted-by":"crossref","unstructured":"Liu A, Lv H, Tan B et al. Accuracy of the highly sensitive C-reactive protein\/albumin ratio to determine disease activity in inflammatory bowel disease. Medicine 2021; 100.","DOI":"10.1097\/MD.0000000000025200"},{"key":"2888_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1745-6215-14-53","volume":"14","author":"AB Chang","year":"2013","unstructured":"Chang AB, Grimwood K, Wilson AC, et al. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. Trials. 2013;14:53.","journal-title":"Trials"},{"key":"2888_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13019-022-01882-y","volume":"17","author":"K Li","year":"2022","unstructured":"Li K, Liu L, Ou Y. The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies. J Cardiothorac Surg. 2022;17:266.","journal-title":"J Cardiothorac Surg"},{"key":"2888_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","volume":"143","author":"MJ Parnham","year":"2014","unstructured":"Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, et al. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014;143:225\u201345.","journal-title":"Pharmacol Ther"},{"key":"2888_CR34","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/archinternmed.2012.3712","volume":"172","author":"JK Bower","year":"2012","unstructured":"Bower JK, Lazo M, Juraschek SP, et al. Within-person variability in high-sensitivity C-reactive protein. Arch Intern Med. 2012;172:1519\u201321.","journal-title":"Arch Intern Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02888-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-02888-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-02888-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T15:04:56Z","timestamp":1708182296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-02888-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2888"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-02888-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"assertion":[{"value":"24 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the University of Hong Kong and Hospital Authority Hong Kong West Cluster (UW 19\u2013624). Patient informed consents were obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}